Oct 16 (Reuters) - Sartorius Ag - :9 months business performance of Bioprocess solutions division in 2017 temporary weaker than expected .Key figures on 9-month business development in 2017.Full-year 2017 guidance adjusted.Mid-term outlook and targets remain unchanged.For first nine months of 2017, Sartorius group achieved revenue growth of 8.6% in constant currencies to about 1.04 billion euros.For first nine months of 2017, Sartorius group achieved an underlying EBIDTA margin of 24.8% versus 9 month 2016 25.0%.Sartorius group now expects that sales revenue in constant currencies will increase by approx. 9% for full-year of 2017.Underlying EBIDTA margin in constant currencies now projected to reach approx. Prior-Year level of around 25.0% for FY 2017.
Oct 16 (Reuters) - Analogic Corp :Plans to re-affirm its fiscal 2018 outlook .Q1 revenue is expected to be lower than Q4 of fiscal 2017 - SEC filing.As a result of co's completed restructuring actions, overall profitability is expected to improve in FY 2018 despite expected lower y-o-y revenues.Fy2018 earnings per share view $2.81 -- Thomson Reuters I/B/E/S.Fy2018 revenue view $453.7 million -- Thomson Reuters I/B/E/S.
Cerner Corp : Cerner reports fourth quarter and full year 2016 results . Sees Q1 2017 adjusted earnings per share $0.57 to $0.59 . Sees FY 2017 adjusted earnings per share $2.44 to $2.56 . Q4 revenue $1.26 billion versus I/B/E/S view $1.26 billion . Q4 adjusted earnings per share $0.61 . Sees Q1 2017 revenue $1.2 billion to $1.275 billion . Sees FY 2017 revenue $5.1 billion to $5.3 billion . Q4 earnings per share view $0.61 -- Thomson Reuters I/B/E/S . Q1 earnings per share view $0.59, revenue view $1.25 billion -- Thomson Reuters I/B/E/S . Fy2017 earnings per share view $2.56, revenue view $5.23 billion -- Thomson Reuters I/B/E/S . Cerner Corp says total backlog of $15.927 billion at quarter-end, up 12 percent over year-ago quarter .Sees Q1 2017 new business bookings between $1.125 billion and $1.275 billion.
PerkinElmer Inc : PerkinElmer announces new organizational structure . Co's diagnostics business will become standalone business segment .Co's environmental health and life science solutions businesses will combine to form discovery & analytical solutions.
Nexstim Oyj : Updates strategy and future outlook . Targeting total annual savings of 2.3 million euros ($2.58 million) . Will streamline organisation both in US and Finland . Estimates that its net sales will decrease during financial year 2016 .Loss for financial year 2016 is expected to be less than for financial year 2015.
Precision System Science Co Ltd <7707.T>: Says it plans to merge with a wholly owned subsidiary, Genetein Co., Ltd . Merger effective date on June 30 .Says the subsidiary will be dissolved after the merger.
China Wah Yan Healthcare Ltd <0648.HK>: Wah yan health-discloseable transactions and adjustment to convertible securities of the company <0648.HK> . The SPV and the group SPV entered into the acquisition agreement and the group SPV . The purchaser and the guarantor entered into the disposal agreement . Cash consideration for acquisition of spv's attributable interest in hospital project co is HK$88.8 million . The cash consideration for the disposal of the group spv's 45% equity interest in spv is HK$89.5 million .
Orion Health Group Ltd : "Targeting revenue growth of over 20% in the coming financial year" . FY operating loss after income tax was NZ$54MLN compared to NZ$61MLN in the previous year . Expects to realise NZ$8 million in on-going cost savings on an annualised basis as a result of reorganising the U.S. business . FY operating revenue of NZ$207MLN, up from NZ$164 million last year .